Submission Details
| 510(k) Number | K945607 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 15, 1994 |
| Decision Date | January 24, 1995 |
| Days to Decision | 70 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
K945607 is an FDA 510(k) clearance for the VARELISA M2 ANTIBODIES, a Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control (Class II — Special Controls, product code DBM), submitted by Elias U.S.A., Inc. (Osceola, US). The FDA issued a Cleared decision on January 24, 1995, 70 days after receiving the submission on November 15, 1994. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5090.
| 510(k) Number | K945607 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 15, 1994 |
| Decision Date | January 24, 1995 |
| Days to Decision | 70 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Statement |
| Product Code | DBM — Antimitochondrial Antibody, Indirect Immunofluorescent, Antigen, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5090 |